Guggenheim Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
|
|||||
|
2025
Q1 | $1.34M | Buy |
|
|||||
|
2024
Q4 | $1.69M | Sell |
|
|||||
|
2024
Q3 | $1.39M | Sell |
|
|||||
|
2024
Q2 | $1.26M | Buy |
|
|||||
|
2024
Q1 | $469K | Buy |
|
|||||
|
2023
Q4 | $267K | Sell |
|
|||||
|
2023
Q3 | $301K | Sell |
|
|||||
|
2023
Q2 | $313K | Sell |
|
|||||
|
2023
Q1 | $401K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $424K | Buy |
|
|||||
|
2021
Q2 | $309K | Buy |
|
|||||
|
2021
Q1 | $298K | Sell |
|
|||||
|
2020
Q4 | $338K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $332K | Sell |
|
|||||
|
2019
Q2 | $579K | Buy |
|
|||||
|
2019
Q1 | $801K | Sell |
|
|||||
|
2018
Q4 | $824K | Buy |
|
|||||
|
2018
Q3 | $1.15M | Buy |
|
|||||
|
2018
Q2 | $1.1M | Sell |
|
|||||
|
2018
Q1 | $969K | Sell |
|
|||||
|
2017
Q4 | $1.28M | Sell |
|
|||||
|
2017
Q3 | $1.32M | Buy |
|
|||||
|
2017
Q2 | $1.43M | Buy |
|
|||||
|
2017
Q1 | $1.33M | Buy |
|
|||||
|
2016
Q4 | $1.46M | Buy |
|
|||||
|
2016
Q3 | $1.83M | Buy |
|
|||||
|
2016
Q2 | $1.98M | Buy |
|
|||||
|
2016
Q1 | $1.66M | Buy |
|
|||||
|
2015
Q4 | $2.01M | Sell |
|
|||||
|
2015
Q3 | $7.76M | Sell |
|
|||||
|
2015
Q2 | $16.6M | Sell |
|
|||||
|
2015
Q1 | $23M | Sell |
|
|||||
|
2014
Q4 | $21.6M | Sell |
|
|||||
|
2014
Q3 | $20.9M | Buy |
|
|||||
|
2014
Q2 | $20.1M | Buy |
|
|||||
|
2014
Q1 | $16.8M | Buy |
|
|||||
|
2013
Q4 | $11.4M | Sell |
|
|||||
|
2013
Q3 | $10.9M | Buy |
|
|||||
|
2013
Q2 | $10.8M | Buy |
|